BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15947645)

  • 1. Chapter 1: The management of erectile dysfunction: an AUA update.
    Montague DK; Jarow JP; Broderick GA; Dmochowski RR; Heaton JP; Lue TF; Milbank AJ; Nehra A; Sharlip ID;
    J Urol; 2005 Jul; 174(1):230-9. PubMed ID: 15947645
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment options broaden. New chances for libido].
    Einecke U
    MMW Fortschr Med; 2002 May; 144(19):4-6. PubMed ID: 12116552
    [No Abstract]   [Full Text] [Related]  

  • 3. [Erectile dysfunction and phosphodiesterase type 5 inhibitors].
    Roumeguère T; Sternon J; Schulman CC
    Rev Med Brux; 2003 Jun; 24(3):169-75. PubMed ID: 12891884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDE-5 inhibitors: current status and future trends.
    Masson P; Lambert SM; Brown M; Shabsigh R
    Urol Clin North Am; 2005 Nov; 32(4):511-25, viii. PubMed ID: 16291042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How I treat and manage erectile dysfunction in diabetics].
    Buvat J
    Journ Annu Diabetol Hotel Dieu; 2006; ():185-203. PubMed ID: 17051861
    [No Abstract]   [Full Text] [Related]  

  • 6. [Some aspects of erectile dysfunction pathogenesis and treatment in patients with obesity].
    Ametov AS; Teodorovich OV; Kondrat'eva LV; Popova AIu
    Ter Arkh; 2006; 78(2):92-4. PubMed ID: 16613108
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of erectile dysfunction in the era of PDE-5 inhibitors.
    Lobo JR; Nehra A
    Urol Clin North Am; 2005 Nov; 32(4):447-55, vi. PubMed ID: 16291036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erectile dysfunction.
    Shabsigh R; Anastasiadis AG
    Annu Rev Med; 2003; 54():153-68. PubMed ID: 12525671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase inhibitors for the treatment of erectile dysfunction.
    Küthe A; Montorsi F; Andersson KE; Stief CG
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1489-95. PubMed ID: 12431025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDE5 inhibitors: looking beyond ED.
    Jackson G
    Int J Clin Pract; 2003 Apr; 57(3):159-60. PubMed ID: 12723713
    [No Abstract]   [Full Text] [Related]  

  • 11. Nitric oxide regulation of penile erection: biology and therapeutic implications.
    Burnett AL
    J Androl; 2002; 23(5):S20-6. PubMed ID: 12236169
    [No Abstract]   [Full Text] [Related]  

  • 12. [Phosphodiesterase-5 inhibitor with broad temporal effectiveness window].
    MMW Fortschr Med; 2004 Apr; 146(16):62. PubMed ID: 15222506
    [No Abstract]   [Full Text] [Related]  

  • 13. Phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Carson CC; Lue TF
    BJU Int; 2005 Aug; 96(3):257-80. PubMed ID: 16042713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [7 years PDE-5 inhibitor for therapy of erection disorders].
    Krankenpfl J; 2005; 43(7-10):267. PubMed ID: 16518894
    [No Abstract]   [Full Text] [Related]  

  • 15. Erectile dysfunction and coronary atherothrombosis in diabetic patients: pathophysiology, clinical features and treatment.
    Gazzaruso C
    Expert Rev Cardiovasc Ther; 2006 Mar; 4(2):173-80. PubMed ID: 16509813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunction.
    Francis SH; Corbin JD
    Urol Clin North Am; 2005 Nov; 32(4):419-29, vi. PubMed ID: 16291034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of erectile dysfunction in the cardiac patient].
    Gratzke C; Becker AJ; Park JW; Reich O; Waldkirch E; Schlenker B; Stief CG
    Dtsch Med Wochenschr; 2005 Dec; 130(50):2899-903. PubMed ID: 16342015
    [No Abstract]   [Full Text] [Related]  

  • 18. Erectile dysfunction drugs and nonarteritic anterior ischemic optic neuropathy.
    Lee AG; Newman NJ
    Am J Ophthalmol; 2005 Oct; 140(4):707-8. PubMed ID: 16226524
    [No Abstract]   [Full Text] [Related]  

  • 19. Erectile dysfunction and cardiovascular considerations: managing patients effectively with phosphodiesterase type 5 inhibitors.
    Hutter AM
    Clin Cardiol; 2004 Apr; 27(4 Suppl 1):I1-2. PubMed ID: 15115188
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Montorsi F; Briganti A; Salonia A; Montorsi P; Rigatti P
    Curr Opin Urol; 2004 Nov; 14(6):357-9. PubMed ID: 15626879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.